Concepedia
Statistics
Publications
13
Citations
402
H-Index
12
Active since
1999
Affiliations
University of Maryland, Baltimore(Current)
National Center for Advancing Translational Sciences
Convergent Engineering (United States)
Kyoto Prefectural University of Medicine
Kyoto University Hospital
Jeffrey Strovel is an author at University of Maryland, Baltimore specializing in oncology, molecular oncology, and pharmacology.
Publications per year
1999–2021
BRD4 Structure–Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536
Lijia Chen, Jeremy L. Yap, Makoto Yoshioka et al. · ACS Medicinal Chemistry Letters · 2015 · 92 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies
Jeffrey Strovel, Sitta Sittampalam, Nathan P. Coussens et al. · 2016 · 57 citations
Pharmacy, Oncology, Pharmacoeconomics +15
Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth
Ahmed A. Mohamed, Charles P. Xavier, Gauthaman Sukumar et al. · Cancer Research · 2018 · 55 citations
Medicine, Oncology, Pharmacology +11
AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model
Hisayuki Yao, Eishi Ashihara, Jeffrey Strovel et al. · Blood Cancer Journal · 2011 · 49 citations · Full text
Life Sciences, Molecular Biology, Oncology +15
Binding of HMG-I(Y) elicits structural changes in a silencer of the human ?-globin gene
Michael B. Chase, Susanne B. Haga, W. David Hankins et al. · American Journal of Hematology · 1999 · 25 citations · Full text
Medicine, Molecular Biology, Molecular Genetics +13
1–5 of 13